1. Barker, FG, Davis, RL, Chang, SM & Prados, MD (1996). Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77: 1161–1166.
2. Bigner, SH, Mark, J & Bigner, DD (1990). Cytogenetics of human brain tumours. Cancer Genet Cytogenet 47: 141–154.
3. Bostrom, J, Cobbers, JMJL, Wolter, M, Tabatabai, G, Weber, RG, Lichter, P, Collins, VP & Reifenberger, G (1998). Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 58: 29–33.
4. Brada, M, Thomas, DGT, Bleehen, NM, Roberts, JT, Senanayake, F, Abram, P, Lantos, PL, Moss, TH, Ironside, JW, Whaley, JB & Stenning, SP (1998). Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in high-grade glioma (HGG)-BRO5. Am Soc Clin Oncol 17: 400a
5. Bruner, JM (1994). Neuropathology of malignant gliomas. Semin Oncol 21: 126–138.